IN BRIEF: Hutchison China Initiates Phase II Trial Of HMPL-453 Read More
IN BRIEF: Hutchison Chi-Med Plans Surufatnib Marketing Application Read More
IN BRIEF: Hutchison China Interim Loss Widens Despite Revenue Growth Read More
IN BRIEF: Hutchison China Amends License Agreement With Eli Lilly Read More
Chi-Med Trials Dual Inhibitor For Hematological Cancer Read More
UK Shareholder Meetings Calendar - Next 7 Days Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
Hutchison China Gets USD100 Million From US Private Equity Firm Read More
IN BRIEF: Hutchison China Gets US FDA Fast Track For Cancer Drug Read More
UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser Read More
UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service Read More
UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks Read More
UK TRADING UPDATE SUMMARY: New Trend Lifestyle Sees Extended Turmoil Read More
Hutchison China Gets US FDA Fast Track Status For Surufatinib Read More
Hutchison China Sees Loss Widen But Lays "Foundations" In 2019 Read More
Hutchison China Prices USD110 Million American Depositary Share Offer Read More
Hutchison China Plans USD110 Million American Depositary Share Offer Read More
Hutchinson China Reports Early Success Of Surufatinib Phase III Study Read More
Hutchison China Starts Phase II Study For Cancer Treatment In China Read More
